**Core Concept**
The Gleason score is a system used to grade the aggressiveness of prostate cancer based on its histological appearance. It is a critical tool for determining the prognosis and guiding treatment decisions for patients with prostate cancer.

**Why the Correct Answer is Right**
The Gleason score is calculated by adding the primary and secondary Gleason grades, which range from 1 (well-differentiated) to 5 (poorly differentiated). A higher Gleason score indicates a more aggressive tumor. In this case, the patient has a Gleason score of 8, which suggests a moderately to poorly differentiated adenocarcinoma. The primary and secondary grades are usually assigned based on the most common patterns of glandular differentiation observed in the biopsy specimen.

**Why Each Wrong Option is Incorrect**
**Option A:** This option might be tempting, but it is not correct because the Gleason score is not a measurement of the size or volume of the tumor. While tumor size can be an important factor in staging and treatment planning, it is not reflected in the Gleason score.
**Option B:** This option is incorrect because the Gleason score is not a measurement of the patient's age or overall health status. While age and comorbidities can influence treatment decisions, they are not directly related to the Gleason score.

**Clinical Pearl / High-Yield Fact**
The Gleason score is a powerful predictor of prostate cancer prognosis, and a score of 8 or higher is often associated with a poorer outcome. It's essential to remember that the Gleason score should be used in conjunction with other clinical factors, such as PSA levels and digital rectal examination findings, to determine the best course of treatment for a patient with prostate cancer.

**Correct Answer:** C.